We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$821M
AUM Growth
-$89.7M
Cap. Flow
-$32.4M
Cap. Flow %
-3.95%
Top 10 Hldgs %
37.68%
Holding
413
New
15
Increased
113
Reduced
149
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 23.71%
2 Technology 16.8%
3 Industrials 8.32%
4 Financials 7.1%
5 Consumer Discretionary 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
226
Exelon
EXC
$47B
$355K 0.04%
+8,765
New +$330K
LH icon
227
Labcorp
LH
$25.9B
$348K 0.04%
1,490
-1,261
-46% -$312K
POOL icon
228
Pool Corp
POOL
$7.5B
$348K 0.04%
738
-561
-43% -$294K
WFC icon
229
Wells Fargo
WFC
$264B
$345K 0.04%
6,423
+392
+6% +$19.3K
IJH icon
230
iShares Core S&P Mid-Cap ETF
IJH
$127B
$344K 0.04%
6,655
-670
-9% -$37.3K
VOT icon
231
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$344K 0.04%
1,601
+12
+0.8% +$3.02K
AMD icon
232
Advanced Micro Devices
AMD
$789B
$343K 0.04%
2,887
-342
-11% -$46K
MINT icon
233
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$343K 0.04%
3,385
-1,229
-27% -$125K
ROST icon
234
Ross Stores
ROST
$81.9B
$340K 0.04%
3,559
+134
+4% +$15K
CTSH icon
235
Cognizant
CTSH
$26B
$334K 0.04%
3,961
+770
+24% +$61.9K
NVO
236
Novo Nordisk
NVO
$209B
$333K 0.04%
6,988
-1,046
-13% -$56.7K
MCHP icon
237
Microchip Technology
MCHP
$46B
$332K 0.04%
4,527
-4,453
-50% -$360K
REGN icon
238
Regeneron Pharmaceuticals
REGN
$80.8B
$330K 0.04%
531
-233
-30% -$143K
XME icon
239
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
$329K 0.04%
7,776
-2,515
-24% -$110K
ABBV icon
240
AbbVie
ABBV
$435B
$326K 0.04%
2,471
-416
-14% -$49.1K
PAYX icon
241
Paychex
PAYX
$42.7B
$324K 0.04%
2,727
-267
-9% -$33K
RMD icon
242
ResMed
RMD
$30.7B
$319K 0.04%
1,355
-15
-1% -$3.89K
GXO icon
243
GXO Logistics
GXO
$5.55B
$317K 0.04%
3,741
+76
+2% +$6.83K
KO icon
244
Coca-Cola
KO
$375B
$316K 0.04%
5,234
-3,321
-39% -$185K
SWKS icon
245
Skyworks Solutions
SWKS
$10.6B
$309K 0.04%
2,207
-76
-3% -$12.2K
PSQ icon
246
ProShares Short QQQ
PSQ
$643M
$306K 0.04%
5,016
-1,212
-19% -$68.2K
XLU icon
247
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$306K 0.04%
8,882
-6,254
-41% -$211K
NIO icon
248
NIO
NIO
$11.9B
$304K 0.04%
11,100
-10,687
-49% -$393K
SMH icon
249
VanEck Semiconductor ETF
SMH
$71.8B
$303K 0.04%
2,232
-546
-20% -$78.9K
DHR.PRA
250
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
$301K 0.04%
+161
New +$334K

Similar funds

Pallas Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Pallas Capital Advisors held 413 positions worth $821M, down 9.9% from $911M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pallas Capital Advisors withdrew a net $32.4M in Q4 2021, closing 63 positions and reducing 149 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Pallas Capital Advisors opened a new position in Janus International worth $21.8M.

  • Pallas Capital Advisors's largest Q4 2021 buy was Janus International: 2,172,601 shares worth $21.8M.
  • Pallas Capital Advisors added most to iShares 0-5 Year TIPS Bond ETF in Q4 2021, an estimated $2.61M increase.
  • Pallas Capital Advisors's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $12M.
  • Pallas Capital Advisors fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2021, selling an estimated $2.44M.
  • Pallas Capital Advisors's ten largest holdings make up 38% of its $821M portfolio in Q4 2021.
  • Pallas Capital Advisors opened 15 new positions and closed 63 in Q4 2021.
  • Pallas Capital Advisors's portfolio value fell 9.9% quarter-over-quarter to $821M.

Based on Pallas Capital Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.